CCND1 and hydrops fetalis: With the aim of targeting the signature genes CDK2 and CCND1 for potential therapy in HF and KF, an initial screening was conducted via the ChEMBL database (https://www.ebi.ac.uk/chembl/) to identify compounds that could simultaneously activate the CDK2 enzyme and inhibit CCND1.